Author: Mario Drungowski
Predictive cancer pathway modelling
CanPathPro in the innovation spotlight, highlighted as an example of best practice in the German biotech sector.
Spot on Innovation! The German Biotechnology Report 2017
See Report here (in German language only):
http://www.ey.com/de/de/industries/life-sciences/ey-biotechnologie-report-2017
CanPathPro’s 1st Annual Meeting has taken place in Amsterdam (The Netherlands) at the Mercure Hotel Amsterdam Sloterdijk Station. Thanks to all participants for a constructive and successful meeting.
The CanPathPro consortium official kick-off meeting was held in Brussels on 12th-13th April 2016 at the EC Commission.
Representatives of all participating institutions met to discuss the crucial next steps for the project, including scientific, technological and administrative aspects.
We were very pleased to have Dr. Ioannis Vouldis in attendance, our EU project officer, who provided the consortium with guidance on H2020 project management issues.
At the working dinner, the consortium had time to further discuss communication and dissemination strategies, including opportunities for early career researchers.
A solid foundation has been laid and we are looking forward to a productive year ahead.
New platform for predictive modelling of cancer signalling: European Consortium ‘CanPathPro’ started
An international group of scientists from 6 countries bring together their expertise to develop a combined experimental and systems biology platform for predictive modelling of cancer signalling. The EU Horizon 2020 funded project, co-ordinated by Alacris Theranostics GmbH, Berlin, will run for 5 years with a budget of almost 11 million euros.
